HYWISPO
Live / Allowed — Notice of allowance issued (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99256152
- Mark type
- Stylized text
- Filed
- 27 Jun 2025
- Published for opposition
- 16 Dec 2025
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, Princeton, NJ, US
Prosecution history
- 10 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION
- 10 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Nov 2025 — ASSIGNED TO EXAMINER
- 07 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Jun 2025 — NEW APPLICATION ENTERED